Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

NCT04335682 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer
Prostate Cancer Metastatic
Prostate Cancer
Castrate Resistant Prostate Cancer
Hormone Sensitive Prostate Cancer
Non-metastatic Prostate Cancer

Interventions

DRUG: Darolutamide
DRUG: Enzalutamide

Sponsor

Alliance Foundation Trials, LLC.

Collaborators

[object Object]